https://www.prnewswire.com/news-releases/protalix-biotherapeutics-hosting-key-opinion-leader-webinar-on-fabry-disease-and-prx-102-301694109.html
0
0
Protalix Biotherapeutics Hosting Key Opinion Leader Webinar on Fabry Disease and PRX-102 USA - English - USA - English - PR Newswire
12/4/22 at 2:00pm
Organization
PRNewswire
Authors
Details
37 words
Summarize
Pharmaceuticals & Biotech Business & Industrial Drugs & Medications Cancer Hosting Key Opinion Leader Protalix Biotherapeutics U.S. Fabry Disease English PRNewswire NYSE American TASE
/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and...
Create an account or login to join the discussion